User profiles for Allan M. Klompas
Allan KlompasAssistant Professor of Anesthesiology Verified email at mayo.edu Cited by 2288 |
Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
…, CC Wiggins, KA Bruno, AM Klompas… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience
…, ES Theel, CC Wiggins, KA Bruno, AM Klompas… - medrxiv, 2020 - medrxiv.org
Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …
diseases that involve the respiratory system. In this context, human convalescent plasma has …
[HTML][HTML] Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
…, MA Golafshar, SA Klassen, AM Klompas… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
[HTML][HTML] Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
[HTML][HTML] Rates among hospitalized patients with COVID-19 treated with Convalescent plasma: A systematic review and meta-analysis
Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19. …
mortality and the differences between subgroups in hospitalized patients with COVID-19. …
Postoperative Transfusions after Administration of Delayed Cold-stored Platelets versus Room Temperature Platelets in Cardiac Surgery: A Retrospective Cohort …
AM Klompas, S Zec, AC Hanson, T Weister… - …, 2023 - pubs.asahq.org
Background Delayed cold storage of room temperature platelets may extend shelf life from
5 to 14 days. The study hypothesized that the use of delayed cold-stored platelets in cardiac …
5 to 14 days. The study hypothesized that the use of delayed cold-stored platelets in cardiac …
[HTML][HTML] Coagulation profile of human COVID-19 convalescent plasma
AM Klompas, N van Helmond, JE Juskewitch… - Scientific reports, 2022 - nature.com
Convalescent plasma is used to treat COVID-19. There are theoretical concerns about the
impact of pro-coagulant factors in convalescent plasma on the coagulation cascade …
impact of pro-coagulant factors in convalescent plasma on the coagulation cascade …
[HTML][HTML] The success of a simulation-based transesophageal echocardiography course for liver transplant anesthesiologists
JM Christensen, JA Nelson, AM Klompas… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Methods: A 4-hour simulation-based learning (SBL) course was provided to improve liver
transplant anesthesiologist TEE knowledge and skill. Learners received training and education …
transplant anesthesiologist TEE knowledge and skill. Learners received training and education …